Replies to post #2576 on PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Kronberg]

Spideyboy I think that Migalastat received FDA OK, just because it is the oral not ERT. If even Amicus takes 15-17% of the Fabry market , this medicine will never make the company profitable. And FOLD still has a market cap of about $ 1.9 B.PRX-102 can get 50+% of the market. And we still with a market value of $63 M. It's hard to believe.
CC apparently has a negative agenda about Protalix. Maybe she was paid, who knows. I wonder if she will continue to write her blogs after such a "great success" of the previous ones.